ProfileGDS4718 / 201138_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 70% 83% 72% 74% 89% 86% 78% 69% 78% 80% 74% 85% 89% 86% 81% 78% 88% 84% 78% 79% 78% 77% 74% 78% 84% 74% 86% 72% 88% 82% 87% 68% 72% 84% 89% 84% 75% 74% 84% 75% 86% 80% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.3568975
GSM549102patient 115, normal, homogenized [OPG study]6.805270
GSM549104patient 119, normal, homogenized [OPG study]8.3290283
GSM549108patient 138, normal, homogenized [OPG study]6.9994972
GSM549119patient 077, normal, homogenized [OPG study]7.1820174
GSM549133patient 032, cancer, homogenized [OPG study]9.1609589
GSM549139patient 042, cancer, homogenized [OPG study]8.6605686
GSM549099patient 107, normal, homogenized [OPG study]7.5351178
GSM549109patient 139, normal, homogenized [OPG study]6.788369
GSM549110patient 046, normal, homogenized [OPG study]7.5395878
GSM549114patient 063, normal, homogenized [OPG study]7.932780
GSM549122patient 082, normal, homogenized [OPG study]7.2106674
GSM549134patient 033, cancer, homogenized [OPG study]8.530985
GSM549136patient 036, cancer, homogenized [OPG study]9.1084689
GSM549140patient 044, cancer, homogenized [OPG study]8.6919386
GSM549111patient 047, normal, homogenized [OPG study]8.0483681
GSM549113patient 057, normal, homogenized [OPG study]7.704978
GSM549132patient 031, cancer, homogenized [OPG study]8.8360788
GSM549137patient 038, cancer, homogenized [OPG study]8.3927784
GSM549142patient 047, cancer, homogenized [OPG study]7.4103678
GSM549100patient 110, normal, homogenized [OPG study]7.6314479
GSM549107patient 135, normal, homogenized [OPG study]7.659878
GSM549115patient 068, normal, homogenized [OPG study]7.5795677
GSM549116patient 072, normal, homogenized [OPG study]7.251274
GSM549120patient 078, normal, homogenized [OPG study]7.6671278
GSM549131patient 030, cancer, homogenized [OPG study]8.5068484
GSM549118patient 074, normal, homogenized [OPG study]7.1959774
GSM549129patient 027, cancer, homogenized [OPG study]8.5332786
GSM549123patient 088, normal, homogenized [OPG study]7.0457372
GSM549124patient 006, cancer, homogenized [OPG study]8.7480788
GSM549126patient 015, cancer, homogenized [OPG study]8.1283982
GSM549128patient 025, cancer, homogenized [OPG study]8.8282987
GSM549103patient 117, normal, homogenized [OPG study]6.6387268
GSM549117patient 073, normal, homogenized [OPG study]6.9659872
GSM549138patient 041, cancer, homogenized [OPG study]8.4228784
GSM549141patient 045, cancer, homogenized [OPG study]9.0539589
GSM549130patient 028, cancer, homogenized [OPG study]8.3016484
GSM549101patient 111, normal, homogenized [OPG study]7.3334875
GSM549105patient 128, normal, homogenized [OPG study]7.2291474
GSM549106patient 134, normal, homogenized [OPG study]8.5174884
GSM549112patient 048, normal, homogenized [OPG study]7.3536575
GSM549125patient 011, cancer, homogenized [OPG study]8.4936386
GSM549127patient 024, cancer, homogenized [OPG study]7.8700780
GSM549135patient 035, cancer, homogenized [OPG study]9.5201591